Cargando…

Treatment of Chinese Patients with Hypertriglyceridemia with a Pharmaceutical-Grade Preparation of Highly Purified Omega-3 Polyunsaturated Fatty Acid Ethyl Esters: Main Results of a Randomized, Double-Blind, Controlled Trial

INTRODUCTION: The lipid-modifying potential of omega-3 polyunsaturated fatty acids in Chinese patients is under-researched. We conducted a multicenter, randomized, placebo-controlled, double-blind, parallel-group study of twice-daily treatment with OMACOR (OM3EE), a prescription-only formulation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Litong, Zhang, Qiuling, Zheng, Zeqi, Pei, Zhaohui, Mao, Hong, Jiang, Tingbo, Kazei, Dmitri, Kahler, Elke, Huo, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450163/ https://www.ncbi.nlm.nih.gov/pubmed/34552329 http://dx.doi.org/10.2147/VHRM.S325217

Ejemplares similares

Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl esters
por: Dayspring, Thomas D
Publicado: (2011)

ODP155 Successful Treatment of PEG-Asparaginase Related Hypertriglyceridemia with Omega-3 Acid Ethyl Esters
por: Radovanovic, Natasa, et al.
Publicado: (2022)

Patient with Hypertriglyceridemia, Type 2 Diabetes, and Chronic Kidney Disease Treated with Atorvastatin and Omega-3 Fatty Acid Ethyl Esters
por: Athyros, Vasilios G, et al.
Publicado: (2012)

Uses and benefits of omega-3 ethyl esters in patients with cardiovascular disease
por: Levantesi, Giacomo, et al.
Publicado: (2010)

Adverse effects of ethyl esters or oxidation products in omega-3 preparations?
por: Rupp, Heinz, et al.
Publicado: (2014)

Icosapent ethyl for the treatment of severe hypertriglyceridemia
por: Fares, Hassan, et al.
Publicado: (2014)

Microalgal feedstock for the production of omega-3 fatty acid ethyl esters and ɛ-polylysine
por: Sivaramakrishnan, Ramachandran, et al.
Publicado: (2021)

Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters
por: Furuhashi, Masato, et al.
Publicado: (2016)

Retrospective Case Series of Patients with Diabetes or Prediabetes Who Were Switched from Omega-3-Acid Ethyl Esters to Icosapent Ethyl
por: Hassan, Amir, et al.
Publicado: (2014)

The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia
por: Backes, James, et al.
Publicado: (2016)

A Review of Omega-3 Ethyl Esters for Cardiovascular Prevention and Treatment of Increased Blood Triglyceride Levels
por: von Schacky, Clemens
Publicado: (2006)

Insight into the Modification of Phosphatidylcholine with n-3 Polyunsaturated Fatty Acids-Rich Ethyl Esters by Immobilized MAS1 Lipase
por: Wang, Xiumei, et al.
Publicado: (2019)

The Novelty of Icosapent Ethyl in the Management of Hypertriglyceridemia and Alleviating Cardiovascular Risk
por: Khan, Muhammad Shoaib, et al.
Publicado: (2021)

Effect of Omega-3 Fatty Acid Ethyl Esters on the Oxylipin Composition of Lipoproteins in Hypertriglyceridemic, Statin-Treated Subjects
por: Newman, John W., et al.
Publicado: (2014)

Azacarbazole n-3 and n-6 polyunsaturated fatty acids ethyl esters nanoemulsion with enhanced efficacy against Plasmodium falciparum
por: Jaromin, Anna, et al.
Publicado: (2020)

New Therapy Using Omega-3-Acid Ethyl Esters for Decubitus Ulcers and Stasis Dermatitis: A Case Report
por: Nagai, Kazuki, et al.
Publicado: (2014)

CMPF, a Metabolite Formed Upon Prescription Omega-3-Acid Ethyl Ester Supplementation, Prevents and Reverses Steatosis
por: Prentice, Kacey J., et al.
Publicado: (2017)

Comparison of pharmacokinetics of omega-3 fatty acid supplements in monoacylglycerol or ethyl ester in humans: a randomized controlled trial
por: Chevalier, Laurie, et al.
Publicado: (2020)

Blood indices of omega-3 and omega-6 polyunsaturated fatty acids are altered in hyperglycemia
por: Alfhili, Mohammad A., et al.
Publicado: (2023)

The Role of Omega-3 Polyunsaturated Fatty Acids in Stroke
por: Bu, Jiyuan, et al.
Publicado: (2016)

Omega 3 polyunsaturated fatty acids and healthy ageing
por: Zhu, Yeyi, et al.
Publicado: (2018)

Omega-3 Polyunsaturated Fatty Acids and Stroke Burden
por: Ueno, Yuji, et al.
Publicado: (2019)

A Head‐to‐Head Comparison of a Free Fatty Acid Formulation of Omega‐3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE‐IT Study
por: Maki, Kevin C., et al.
Publicado: (2022)

Pharmacokinetics of Supplemental Omega-3 Fatty Acids Esterified in Monoglycerides, Ethyl Esters, or Triglycerides in Adults in a Randomized Crossover Trial
por: Chevalier, Laurie, et al.
Publicado: (2021)

Glycine ethyl ester hydrochloride
por: He, Yong-Jun, et al.
Publicado: (2010)

Update on the management of severe hypertriglyceridemia – focus on free fatty acid forms of omega-3
por: Pirillo, Angela, et al.
Publicado: (2015)

Omega-3 Polyunsaturated Fatty Acids and Heart Rate Variability
por: Christensen, Jeppe Hagstrup
Publicado: (2011)

Omega-3 polyunsaturated fatty acids and cardiac rhythm: an introduction
por: Billman, George E.
Publicado: (2012)

Heterologous Reconstitution of Omega-3 Polyunsaturated Fatty Acids in Arabidopsis
por: Kim, Sun Hee, et al.
Publicado: (2015)

Omega-3 Polyunsaturated Fatty Acids: Benefits and Endpoints in Sport
por: Gammone, Maria Alessandra, et al.
Publicado: (2018)

An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health
por: Elagizi, Andrew, et al.
Publicado: (2021)

Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health
por: Rodriguez, Daniel, et al.
Publicado: (2022)

Omega-3 Fatty Acid Ethyl Esters do not Improve Clopidogrel Associated P2Y12 Inhibition in Stroke Patients
por: Li, Ping, et al.
Publicado: (2015)

Lipid-lowering and anti-inflammatory effects of omega 3 ethyl esters and krill oil: a randomized, cross-over, clinical trial
por: Cicero, Arrigo F.G., et al.
Publicado: (2016)

New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids
por: de Lorgeril, Michel, et al.
Publicado: (2012)

Omega-3 Versus Omega-6 Polyunsaturated Fatty Acids in the Prevention and Treatment of Inflammatory Skin Diseases
por: Balić, Anamaria, et al.
Publicado: (2020)

Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021
por: Djuricic, Ivana, et al.
Publicado: (2021)

Blood Pressure–Lowering Effects of Omega‐3 Polyunsaturated Fatty Acids: Are These the Missing Link to Explain the Relationship Between Omega‐3 Polyunsaturated Fatty Acids and Cardiovascular Disease?
por: George, Marc, et al.
Publicado: (2022)

Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment
por: Weintraub, William S., et al.
Publicado: (2022)

Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia
por: Han, Eugene, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kd5irstft8nt0ebfoffthnq055